0.00Open0.06Pre Close0 Volume1.14K Open Interest3.00Strike Price0.00Turnover0.00%IV-60.97%PremiumJan 17, 2025Expiry Date4.84Intrinsic Value100Multiplier-4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma130.67Leverage Ratio--Theta--Rho--Eff Leverage--Vega
bluebird bio Stock Discussion
Year-End Market Trends (“Santa Claus Rally”)
1. Santa Claus Rally:
Historically, U.S. markets often experience a “Santa Claus Rally” during the last week of December through the first two trading days of ...
Aritificial Intelligence: $C3.ai (AI.US)$ $Verint Systems (VRNT.US)$
Data Center: $Super Micro Computer (SMCI.US)$
Data Analytics: $Palantir (PLTR.US)$
Blockchain: $Riot Platforms (RIOT.US)$
Health Technology: $Cardio Diagnostics (CDIO.US)$
Biotechnology: $bluebird bio (BLUE.US)$ $Quantum-Si (QSI.US)$
Going Viral: The Trend Everyone’s Talking About! | 爆红:人人热议的趋势!
Join us in the group chat BxB Circle.
...
$Checkpoint Therapeutics (CKPT.US)$ $Fortress Biotech (FBIO.US)$ FDA approval of drug for metastatic cutaneous squamous cell carcinoma. This drug is the first and only progr...
Renovaro focuses on AI-driven healthcare innovation, particularly in early cancer detection and immunotherapy. Their flagship product, RenovaroCube, uses AI for diagnostics. The company has also acquired GEDi Cube and formed partnerships with institutions like Amsterdam UMC Cancer Center. Recent restructuring includes appointing David Weinstein as CEO .
2. $Rigetti Computing (RGTI.US)$Rigetti Co...
No comment yet